Sanitar Co., Ltd.(TW:1817)
NT$39.70+0.30 (+1.15%)
TW:1817
Sanitar Co., Ltd. financials statements
NT$39.70
At close:+0.30 (+1.15%)
Sanitar Co., Ltd. (1817) Ratios
Sanitar Co., Ltd. Ratios
TW:1817's free cash flow for Q2 2026 was NT$38.83M. For the 2026 fiscal year, TW:1817's free cash flow was decreased by NT$-6.54M and operating cash flow was NT$45.38M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.80 | 5.80 | 3.84 | 3.45 | 2.40 |
| Quick Ratio | 2.76 | 3.02 | 1.97 | 1.64 | 1.17 |
| Cash Ratio | 0.99 | 0.84 | 0.74 | 0.57 | 0.45 |
| Solvency Ratio | 0.57 | 0.76 | 0.53 | 0.58 | 0.36 |
| Operating Cash Flow Ratio | 1.23 | 1.04 | 0.83 | 0.82 | 0.41 |
| Short-Term Operating Cash Flow Coverage | 5.16 | 16.79 | 2.86 | 3.10 | 0.90 |
| Net Current Asset Value | NT$ 1.18B | NT$ 1.17B | NT$ 892.99M | NT$ 776.91M | NT$ 517.78M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.04 | 0.08 | 0.08 | 0.16 |
| Debt-to-Equity Ratio | 0.08 | 0.05 | 0.10 | 0.11 | 0.25 |
| Debt-to-Capital Ratio | 0.07 | 0.05 | 0.09 | 0.10 | 0.20 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.05 |
| Financial Leverage Ratio | 1.30 | 1.27 | 1.35 | 1.37 | 1.53 |
| Debt Service Coverage Ratio | 3.82 | 18.46 | 2.90 | 3.41 | 1.22 |
| Interest Coverage Ratio | 70.42 | 73.62 | 49.08 | 50.24 | 42.28 |
| Debt to Market Cap | 0.03 | 0.01 | 0.05 | 0.05 | 0.14 |
| Interest Debt Per Share | 2.38 | 1.58 | 2.95 | 3.17 | 6.19 |
| Net Debt to EBITDA | -0.46 | -0.27 | -0.21 | -0.05 | 0.42 |
| Profitability Margins | |||||
| Gross Profit Margin | 34.88% | 35.46% | 34.29% | 34.44% | 33.61% |
| EBIT Margin | 13.68% | 14.82% | 12.56% | 14.65% | 12.42% |
| EBITDA Margin | 17.42% | 18.69% | 17.09% | 18.88% | 17.04% |
| Operating Profit Margin | 13.68% | 13.47% | 11.54% | 14.54% | 12.60% |
| Pretax Profit Margin | 13.53% | 14.64% | 12.33% | 14.36% | 12.13% |
| Net Profit Margin | 10.06% | 11.30% | 9.42% | 10.89% | 9.33% |
| Continuous Operations Profit Margin | 10.06% | 11.51% | 9.50% | 11.06% | 9.61% |
| Net Income Per EBT | 74.36% | 77.16% | 76.44% | 75.85% | 76.94% |
| EBT Per EBIT | 98.91% | 108.71% | 106.81% | 98.80% | 96.21% |
| Return on Assets (ROA) | 8.99% | 11.07% | 8.72% | 10.66% | 8.11% |
| Return on Equity (ROE) | 11.73% | 14.03% | 11.74% | 14.57% | 12.44% |
| Return on Capital Employed (ROCE) | 14.05% | 14.74% | 12.55% | 16.89% | 14.06% |
| Return on Invested Capital (ROIC) | 10.03% | 11.43% | 9.13% | 12.30% | 9.67% |
| Return on Tangible Assets | 9.02% | 11.11% | 8.76% | 10.72% | 8.15% |
| Earnings Yield | 9.43% | 10.60% | 8.87% | 10.66% | 8.32% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.13 | 7.27 | 6.69 | 7.97 | 7.45 |
| Payables Turnover | 19.74 | 23.88 | 16.96 | 16.18 | 11.38 |
| Inventory Turnover | 2.21 | 2.17 | 2.18 | 2.26 | 2.13 |
| Fixed Asset Turnover | 2.73 | 2.69 | 2.37 | 2.33 | 2.02 |
| Asset Turnover | 0.89 | 0.98 | 0.93 | 0.98 | 0.87 |
| Working Capital Turnover Ratio | 1.82 | 2.16 | 2.28 | 2.82 | 3.35 |
| Cash Conversion Cycle | 191.75 | 203.46 | 200.24 | 184.74 | 188.46 |
| Days of Sales Outstanding | 44.88 | 50.21 | 54.55 | 45.79 | 49.00 |
| Days of Inventory Outstanding | 165.36 | 168.54 | 167.22 | 161.50 | 171.54 |
| Days of Payables Outstanding | 18.49 | 15.28 | 21.52 | 22.55 | 32.08 |
| Operating Cycle | 210.25 | 218.74 | 221.76 | 207.30 | 220.54 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 6.40 | 4.28 | 4.65 | 4.91 | 3.43 |
| Free Cash Flow Per Share | 5.80 | 3.46 | 4.15 | 4.59 | 2.99 |
| Dividend Paid and CapEx Coverage Ratio | 2.14 | 1.64 | 1.70 | 2.12 | 1.41 |
| Capital Expenditure Coverage Ratio | 10.58 | 5.21 | 10.49 | 15.26 | 7.75 |
| Operating Cash Flow Coverage Ratio | 2.77 | 2.84 | 1.62 | 1.60 | 0.56 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.11 | 0.13 | 0.13 | 0.10 |
| Free Cash Flow Yield | 15.14% | 8.40% | 11.27% | 12.13% | 8.11% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 10.61 | 9.41 | 11.27 | 9.37 | 12.02 |
| Price-to-Sales (P/S) Ratio | 1.07 | 1.07 | 1.06 | 1.02 | 1.12 |
| Price-to-Book (P/B) Ratio | 1.24 | 1.32 | 1.32 | 1.37 | 1.49 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6.61 | 11.91 | 8.87 | 8.24 | 12.34 |
| Price-to-Operating Cash Flow Ratio | 5.98 | 9.62 | 7.92 | 7.70 | 10.74 |
| Price-to-Earnings Growth (PEG) Ratio | -0.60 | 0.28 | -0.59 | 0.30 | 12.18 |
| Enterprise Value Multiple | 5.67 | 5.43 | 6.00 | 5.36 | 7.00 |
| Enterprise Value | 2.59B | 2.83B | 2.56B | 2.70B | 2.83B |
| EV to EBITDA | 5.67 | 5.43 | 6.00 | 5.36 | 7.00 |
| EV to Sales | 0.99 | 1.02 | 1.03 | 1.01 | 1.19 |
| EV to Free Cash Flow | 6.11 | 11.33 | 8.56 | 8.17 | 13.13 |
| EV to Operating Cash Flow | 5.54 | 9.16 | 7.65 | 7.63 | 11.43 |
| Tangible Book Value Per Share | 31.27 | 31.52 | 28.22 | 27.87 | 24.85 |
| Shareholders’ Equity Per Share | 30.78 | 31.11 | 27.86 | 27.70 | 24.69 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.21 | 0.23 | 0.23 | 0.22 |
| Revenue Per Share | 35.87 | 38.64 | 34.71 | 37.04 | 32.92 |
| Net Income Per Share | 3.61 | 4.37 | 3.27 | 4.04 | 3.07 |
| Tax Burden | 0.74 | 0.77 | 0.76 | 0.76 | 0.77 |
| Interest Burden | 0.99 | 0.99 | 0.98 | 0.98 | 0.98 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.22 | 0.21 | 0.21 | 0.19 | 0.20 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.78 | 0.98 | 1.42 | 0.92 | 0.86 |
Currency in TWD
